Prescription Drugs

Event ID #   15703
WUNRN-Women's UN Report Network
Opioids, Substance Abuse Disorders, Are a Threat to Human Rights
Tuesday, March 19 – 2:30 pm
Dr. Lori Post was the moderator of the session and presented the BJA project-using data to combat drug overdoses and explained the drug data center we are developing. Dr. Jay Unick presented on community-based treatment, and Dr. Maryann Mason presented on additional barriers that women face.

The Center has provided financial support to invite a subject matter expert Dr. Stuart Wasser to present at the PA Association of Treatment Court Professionals 2023 Conference that took place October 11-13, 2023. Dr. Wasser delivered a presentation titled "The MOUD Prescriber Perspective: Facilitators and Barriers to Induction". This session provided a brief overview of the major medications commonly used in the treatment of opioid use disorder. The efficacy of MAT and current best practices were discussed.

Dr. Lori Post presented Ohio River Valley Corridor drug data to the State of Ohio government at the Ohio Narcotics Intelligence Center (ONIC)/Quarterly Emerging Drugs Scientific Working Group (EDSWG) meeting. Information was presented about hot spots of opioid overdose death rates and compared to hot spots of drug violation arrests within the state of Ohio and across state borders. This data was broken down and compared by county, state, region, and the United States as a whole.

Illinois Public Media was interested in knowing what substances were detected in toxicology results in people who die by suicide via firearms or hanging/strangulation. Dr. Lori Post was interviewed for the segment that aired on January 11, 2024. Data was analyzed to determine what substances were more likely to be found in toxicology testing in suicides by different mechanisms. For example, in toxicology results from suicides by firearms, it was more likely to find positive results for stimulants.

IIR has not yet received financial clearance to expend funds from the supplemental funding award; therefore, no activities have occurred under this deliverable. It is anticipated that work will begin early in the next reporting period.

Work on this deliverable was placed on hold for this reporting period because of IHS not moving forward to work with RxCheck.

During this reporting period, the IJIS team learned that IHS contracted with BH to provide it with PDMP/EHR integration solutions. IHS has opted to explore another vendor technology solution to provide PDMP/EHR integration rather than using its own tested and proven technology with the RxCheck Hub. The CDC advised IJIS to focus on non-IHS tribal integrations until IHS establishes a PDMP/EHR integration with BH or comes back to the table to discuss integration options.

Work on this deliverable was placed on hold for this reporting period because of IHS not moving forward to work with RxCheck.

During this reporting period, the IJIS team learned that IHS has contracted with BH to provide it with PDMP/EHR integration solutions. IHS has opted to explore another vendor technology solution for provision of PDMP/EHR integration rather than using its own tested and proven technology with the RxCheck Hub.

In July 2023, IJIS held two conference calls with DIHFS, including representatives from eClinicalWorks (eCW), the EMRs vendor for DIHFS. During those meetings eCW indicated that they would engage this project with their technology teams and requested that IJIS complete a Business Partner Relationship form to expedite the development process, which IJIS did. In these meetings, it was established that eCW had developed two PDMP/EHR endpoints, one with Bamboo Health (BH) and the other with LogiCoy Health (LCY).